Stellantis Forges Unique Path Amid EU Tariffs on Chinese Electric Vehicles Goldman Sachs Maintains Bullish Gold Outlook Amid Rising Central Bank Demand Government to Offload Up to 2 Stake in Coal India via Offer for Sale at Rs 412Share Floor Price Rise in Solar Panel Purchases Driven by Energy Cost Savings Company Director Invests in 2000 Panels SpaceX and OpenAI IPOs Could Surpass Berkshire Hathaway on Debut Day Prediction Markets Suggest SpaceX Scrubs Starship Test Flight Aims for Friday Launch Amid Ambitious Space Goals Scienture Holdings Inc SCNX Q1 2026 Earnings EPS Surprise of 64 Narrows Loss Amid Strategic Progress Leslies Inc Q1 2026 Earnings Significant EPS Miss Despite Strong Stock Rally ARRY Q1 2026 Earnings Earnings Surge Past Estimates Despite Revenue Uncertainty LOMA Q1 2026 Earnings Strong EPS Delivery Amidst Macro Uncertainty SUPV Q1 2026 Earnings Stellar Earnings Surprise as EPS Beats Estimates by Wide Margin DK Q1 2026 Earnings Surprise Profit Defies Expectations as Refining Margins Improve Intuitive Surgical ISRG Drops Over 4 as Key Support Levels Tested Neuronetics STIM Edges Higher Amid Cautious Trading Quanex Building Products NX Surges 3 as Homebuilding Sector Finds Footing Insmed Surges 248 as Biotech Stock Tests Key Resistance Yalla Group Limited YALA Holds Steady at 620 Amid Modest Gains Stock Markets Gain as USIran Talks Show Progress Treasury Yields Dip Haverty Furniture HVT Q1 2026 Earnings EPS Slightly Misses Estimates Stock Edges Higher Darden Restaurants DRI Holds Steady Near 205 as Mixed Signals Keep Traders Cautious VersaBank VBNK Q1 2026 Earnings EPS Miss Amid Challenging Quarter WKC Q1 2026 Earnings Massive EPS Beat Drives Consideration but Shares Edge Lower TOON Q3 2018 Earnings WiderThanExpected Loss Despite Stock Rally RWAY Q1 2026 Earnings EPS Misses Estimates but Stock Gains as Portfolio Remains Resilient TROW Q1 2026 Earnings EPS Surges Past Estimates Amid Strong Market Performance Amicus Therapeutics Q4 2025 Earnings EPS Misses Expectations by a Wide Margin ANNX Q1 2026 Earnings EPS Beat Surprise as ClinicalStage Biotech Tightens Cost Control